Neovacs SA (FR:ALNEV) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neovacs SA has announced a fundraising initiative of €0.25 million through the issue of OCEANE-BSA securities to finance their Kinoïde research program and bolster investment in biotech and medtech projects. The fundraising could potentially create 500 million new shares, diluting current shareholders’ stakes. The company focuses on developing vaccine candidates and investing in high-potential biotech and medtech companies.
For further insights into FR:ALNEV stock, check out TipRanks’ Stock Analysis page.